Global Antiasthmatic Drug Market Research Report 2022

Global Antiasthmatic Drug Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiasthmatic Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Bronchodilators
1.2.3 Anti-allergic Antiasthmatic
1.2.4 Anti-inflammatory Antiasthmatic
1.3 Market by Application
1.3.1 Global Antiasthmatic Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Need for Acute Attack of Asthma
1.3.3 Treatment of Chronic Asthma
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antiasthmatic Drug Market Perspective (2017-2028)
2.2 Antiasthmatic Drug Growth Trends by Region
2.2.1 Antiasthmatic Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Antiasthmatic Drug Historic Market Size by Region (2017-2022)
2.2.3 Antiasthmatic Drug Forecasted Market Size by Region (2023-2028)
2.3 Antiasthmatic Drug Market Dynamics
2.3.1 Antiasthmatic Drug Industry Trends
2.3.2 Antiasthmatic Drug Market Drivers
2.3.3 Antiasthmatic Drug Market Challenges
2.3.4 Antiasthmatic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiasthmatic Drug Players by Revenue
3.1.1 Global Top Antiasthmatic Drug Players by Revenue (2017-2022)
3.1.2 Global Antiasthmatic Drug Revenue Market Share by Players (2017-2022)
3.2 Global Antiasthmatic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antiasthmatic Drug Revenue
3.4 Global Antiasthmatic Drug Market Concentration Ratio
3.4.1 Global Antiasthmatic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiasthmatic Drug Revenue in 2021
3.5 Antiasthmatic Drug Key Players Head office and Area Served
3.6 Key Players Antiasthmatic Drug Product Solution and Service
3.7 Date of Enter into Antiasthmatic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiasthmatic Drug Breakdown Data by Type
4.1 Global Antiasthmatic Drug Historic Market Size by Type (2017-2022)
4.2 Global Antiasthmatic Drug Forecasted Market Size by Type (2023-2028)
5 Antiasthmatic Drug Breakdown Data by Application
5.1 Global Antiasthmatic Drug Historic Market Size by Application (2017-2022)
5.2 Global Antiasthmatic Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Antiasthmatic Drug Market Size (2017-2028)
6.2 North America Antiasthmatic Drug Market Size by Country (2017-2022)
6.3 North America Antiasthmatic Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Antiasthmatic Drug Market Size (2017-2028)
7.2 Europe Antiasthmatic Drug Market Size by Country (2017-2022)
7.3 Europe Antiasthmatic Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiasthmatic Drug Market Size (2017-2028)
8.2 Asia-Pacific Antiasthmatic Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Antiasthmatic Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Antiasthmatic Drug Market Size (2017-2028)
9.2 Latin America Antiasthmatic Drug Market Size by Country (2017-2022)
9.3 Latin America Antiasthmatic Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiasthmatic Drug Market Size (2017-2028)
10.2 Middle East & Africa Antiasthmatic Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Antiasthmatic Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Antiasthmatic Drug Introduction
11.1.4 Novartis AG Revenue in Antiasthmatic Drug Business (2017-2022)
11.1.5 Novartis AG Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Antiasthmatic Drug Introduction
11.2.4 GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2017-2022)
11.2.5 GlaxoSmithKline Recent Development
11.3 ABC Farmaceutici Spa
11.3.1 ABC Farmaceutici Spa Company Detail
11.3.2 ABC Farmaceutici Spa Business Overview
11.3.3 ABC Farmaceutici Spa Antiasthmatic Drug Introduction
11.3.4 ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2017-2022)
11.3.5 ABC Farmaceutici Spa Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Antiasthmatic Drug Introduction
11.4.4 AstraZeneca Revenue in Antiasthmatic Drug Business (2017-2022)
11.4.5 AstraZeneca Recent Development
11.5 Teva Pharmaceutical Industries Ltd
11.5.1 Teva Pharmaceutical Industries Ltd Company Detail
11.5.2 Teva Pharmaceutical Industries Ltd Business Overview
11.5.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Introduction
11.5.4 Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2017-2022)
11.5.5 Teva Pharmaceutical Industries Ltd Recent Development
11.6 Mundipharma Pharmaceuticals Ltd.
11.6.1 Mundipharma Pharmaceuticals Ltd. Company Detail
11.6.2 Mundipharma Pharmaceuticals Ltd. Business Overview
11.6.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Introduction
11.6.4 Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2017-2022)
11.6.5 Mundipharma Pharmaceuticals Ltd. Recent Development
11.7 MSD
11.7.1 MSD Company Detail
11.7.2 MSD Business Overview
11.7.3 MSD Antiasthmatic Drug Introduction
11.7.4 MSD Revenue in Antiasthmatic Drug Business (2017-2022)
11.7.5 MSD Recent Development
11.8 Daiichi Sankyo Company Limited
11.8.1 Daiichi Sankyo Company Limited Company Detail
11.8.2 Daiichi Sankyo Company Limited Business Overview
11.8.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Introduction
11.8.4 Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2017-2022)
11.8.5 Daiichi Sankyo Company Limited Recent Development
11.9 Chiesi GmbH
11.9.1 Chiesi GmbH Company Detail
11.9.2 Chiesi GmbH Business Overview
11.9.3 Chiesi GmbH Antiasthmatic Drug Introduction
11.9.4 Chiesi GmbH Revenue in Antiasthmatic Drug Business (2017-2022)
11.9.5 Chiesi GmbH Recent Development
11.10 Kyorin Pharmaceutical Co.,Ltd.
11.10.1 Kyorin Pharmaceutical Co.,Ltd. Company Detail
11.10.2 Kyorin Pharmaceutical Co.,Ltd. Business Overview
11.10.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Introduction
11.10.4 Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2017-2022)
11.10.5 Kyorin Pharmaceutical Co.,Ltd. Recent Development
11.11 Kissei Pharmaceutical Co.Ltd.
11.11.1 Kissei Pharmaceutical Co.Ltd. Company Detail
11.11.2 Kissei Pharmaceutical Co.Ltd. Business Overview
11.11.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Introduction
11.11.4 Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2017-2022)
11.11.5 Kissei Pharmaceutical Co.Ltd. Recent Development
11.12 Ruiyang Pharmaceutical Co., Ltd
11.12.1 Ruiyang Pharmaceutical Co., Ltd Company Detail
11.12.2 Ruiyang Pharmaceutical Co., Ltd Business Overview
11.12.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.12.4 Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022)
11.12.5 Ruiyang Pharmaceutical Co., Ltd Recent Development
11.13 Chiesi Pharmaceutical (Shangai) Co., Ltd
11.13.1 Chiesi Pharmaceutical (Shangai) Co., Ltd Company Detail
11.13.2 Chiesi Pharmaceutical (Shangai) Co., Ltd Business Overview
11.13.3 Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic Drug Introduction
11.13.4 Chiesi Pharmaceutical (Shangai) Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022)
11.13.5 Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Development
11.14 Fuhe Group
11.14.1 Fuhe Group Company Detail
11.14.2 Fuhe Group Business Overview
11.14.3 Fuhe Group Antiasthmatic Drug Introduction
11.14.4 Fuhe Group Revenue in Antiasthmatic Drug Business (2017-2022)
11.14.5 Fuhe Group Recent Development
11.15 Lunan Pharmaceutical Group Co., Ltd
11.15.1 Lunan Pharmaceutical Group Co., Ltd Company Detail
11.15.2 Lunan Pharmaceutical Group Co., Ltd Business Overview
11.15.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Introduction
11.15.4 Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022)
11.15.5 Lunan Pharmaceutical Group Co., Ltd Recent Development
11.16 Chengdu Huayu Pharmaceutical Co., Ltd
11.16.1 Chengdu Huayu Pharmaceutical Co., Ltd Company Detail
11.16.2 Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
11.16.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.16.4 Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022)
11.16.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Development
11.17 Kaifeng Kangnuo Pharmaceutical Co., Ltd
11.17.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Detail
11.17.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
11.17.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Introduction
11.17.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022)
11.17.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Development
11.18 Akorn Pharmaceutical Co.Ltd.
11.18.1 Akorn Pharmaceutical Co.Ltd. Company Detail
11.18.2 Akorn Pharmaceutical Co.Ltd. Business Overview
11.18.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Introduction
11.18.4 Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2017-2022)
11.18.5 Akorn Pharmaceutical Co.Ltd. Recent Development
11.19 Boehringer Ingelheim Pharma GmbH&Co.KG
11.19.1 Boehringer Ingelheim Pharma GmbH&Co.KG Company Detail
11.19.2 Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
11.19.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Introduction
11.19.4 Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2017-2022)
11.19.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Development
11.20 Covis Pharmaceutical Inc
11.20.1 Covis Pharmaceutical Inc Company Detail
11.20.2 Covis Pharmaceutical Inc Business Overview
11.20.3 Covis Pharmaceutical Inc Antiasthmatic Drug Introduction
11.20.4 Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2017-2022)
11.20.5 Covis Pharmaceutical Inc Recent Development
11.21 Roche
11.21.1 Roche Company Detail
11.21.2 Roche Business Overview
11.21.3 Roche Antiasthmatic Drug Introduction
11.21.4 Roche Revenue in Antiasthmatic Drug Business (2017-2022)
11.21.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Antiasthmatic Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Anti-allergic Antiasthmatic
Table 4. Key Players of Anti-inflammatory Antiasthmatic
Table 5. Global Antiasthmatic Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Antiasthmatic Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Antiasthmatic Drug Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Antiasthmatic Drug Market Share by Region (2017-2022)
Table 9. Global Antiasthmatic Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Antiasthmatic Drug Market Share by Region (2023-2028)
Table 11. Antiasthmatic Drug Market Trends
Table 12. Antiasthmatic Drug Market Drivers
Table 13. Antiasthmatic Drug Market Challenges
Table 14. Antiasthmatic Drug Market Restraints
Table 15. Global Antiasthmatic Drug Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Antiasthmatic Drug Market Share by Players (2017-2022)
Table 17. Global Top Antiasthmatic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2021)
Table 18. Ranking of Global Top Antiasthmatic Drug Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Antiasthmatic Drug Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antiasthmatic Drug Product Solution and Service
Table 22. Date of Enter into Antiasthmatic Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiasthmatic Drug Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Antiasthmatic Drug Revenue Market Share by Type (2017-2022)
Table 26. Global Antiasthmatic Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Antiasthmatic Drug Revenue Market Share by Type (2023-2028)
Table 28. Global Antiasthmatic Drug Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Antiasthmatic Drug Revenue Market Share by Application (2017-2022)
Table 30. Global Antiasthmatic Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Antiasthmatic Drug Revenue Market Share by Application (2023-2028)
Table 32. North America Antiasthmatic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Antiasthmatic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Antiasthmatic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Antiasthmatic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Antiasthmatic Drug Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Antiasthmatic Drug Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Antiasthmatic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Antiasthmatic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Antiasthmatic Drug Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Antiasthmatic Drug Market Size by Country (2023-2028) & (US$ Million)
Table 42. Novartis AG Company Detail
Table 43. Novartis AG Business Overview
Table 44. Novartis AG Antiasthmatic Drug Product
Table 45. Novartis AG Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 46. Novartis AG Recent Development
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline Antiasthmatic Drug Product
Table 50. GlaxoSmithKline Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. ABC Farmaceutici Spa Company Detail
Table 53. ABC Farmaceutici Spa Business Overview
Table 54. ABC Farmaceutici Spa Antiasthmatic Drug Product
Table 55. ABC Farmaceutici Spa Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 56. ABC Farmaceutici Spa Recent Development
Table 57. AstraZeneca Company Detail
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca Antiasthmatic Drug Product
Table 60. AstraZeneca Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Teva Pharmaceutical Industries Ltd Company Detail
Table 63. Teva Pharmaceutical Industries Ltd Business Overview
Table 64. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product
Table 65. Teva Pharmaceutical Industries Ltd Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 66. Teva Pharmaceutical Industries Ltd Recent Development
Table 67. Mundipharma Pharmaceuticals Ltd. Company Detail
Table 68. Mundipharma Pharmaceuticals Ltd. Business Overview
Table 69. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product
Table 70. Mundipharma Pharmaceuticals Ltd. Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 71. Mundipharma Pharmaceuticals Ltd. Recent Development
Table 72. MSD Company Detail
Table 73. MSD Business Overview
Table 74. MSD Antiasthmatic Drug Product
Table 75. MSD Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 76. MSD Recent Development
Table 77. Daiichi Sankyo Company Limited Company Detail
Table 78. Daiichi Sankyo Company Limited Business Overview
Table 79. Daiichi Sankyo Company Limited Antiasthmatic Drug Product
Table 80. Daiichi Sankyo Company Limited Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 81. Daiichi Sankyo Company Limited Recent Development
Table 82. Chiesi GmbH Company Detail
Table 83. Chiesi GmbH Business Overview
Table 84. Chiesi GmbH Antiasthmatic Drug Product
Table 85. Chiesi GmbH Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 86. Chiesi GmbH Recent Development
Table 87. Kyorin Pharmaceutical Co.,Ltd. Company Detail
Table 88. Kyorin Pharmaceutical Co.,Ltd. Business Overview
Table 89. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product
Table 90. Kyorin Pharmaceutical Co.,Ltd. Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 91. Kyorin Pharmaceutical Co.,Ltd. Recent Development
Table 92. Kissei Pharmaceutical Co.Ltd. Company Detail
Table 93. Kissei Pharmaceutical Co.Ltd. Business Overview
Table 94. Kissei Pharmaceutical Co.Ltd. Antiasthmatic DrugProduct
Table 95. Kissei Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 96. Kissei Pharmaceutical Co.Ltd. Recent Development
Table 97. Ruiyang Pharmaceutical Co., Ltd Company Detail
Table 98. Ruiyang Pharmaceutical Co., Ltd Business Overview
Table 99. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic DrugProduct
Table 100. Ruiyang Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 101. Ruiyang Pharmaceutical Co., Ltd Recent Development
Table 102. Chiesi Pharmaceutical (Shangai) Co., Ltd Company Detail
Table 103. Chiesi Pharmaceutical (Shangai) Co., Ltd Business Overview
Table 104. Chiesi Pharmaceutical (Shangai) Co., Ltd Antiasthmatic DrugProduct
Table 105. Chiesi Pharmaceutical (Shangai) Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 106. Chiesi Pharmaceutical (Shangai) Co., Ltd Recent Development
Table 107. Fuhe Group Company Detail
Table 108. Fuhe Group Business Overview
Table 109. Fuhe Group Antiasthmatic DrugProduct
Table 110. Fuhe Group Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 111. Fuhe Group Recent Development
Table 112. Lunan Pharmaceutical Group Co., Ltd Company Detail
Table 113. Lunan Pharmaceutical Group Co., Ltd Business Overview
Table 114. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic DrugProduct
Table 115. Lunan Pharmaceutical Group Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 116. Lunan Pharmaceutical Group Co., Ltd Recent Development
Table 117. Chengdu Huayu Pharmaceutical Co., Ltd Company Detail
Table 118. Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
Table 119. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic DrugProduct
Table 120. Chengdu Huayu Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 121. Chengdu Huayu Pharmaceutical Co., Ltd Recent Development
Table 122. Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Detail
Table 123. Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
Table 124. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic DrugProduct
Table 125. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 126. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Development
Table 127. Akorn Pharmaceutical Co.Ltd. Company Detail
Table 128. Akorn Pharmaceutical Co.Ltd. Business Overview
Table 129. Akorn Pharmaceutical Co.Ltd. Antiasthmatic DrugProduct
Table 130. Akorn Pharmaceutical Co.Ltd. Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 131. Akorn Pharmaceutical Co.Ltd. Recent Development
Table 132. Boehringer Ingelheim Pharma GmbH&Co.KG Company Detail
Table 133. Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
Table 134. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic DrugProduct
Table 135. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 136. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Development
Table 137. Covis Pharmaceutical Inc Company Detail
Table 138. Covis Pharmaceutical Inc Business Overview
Table 139. Covis Pharmaceutical Inc Antiasthmatic DrugProduct
Table 140. Covis Pharmaceutical Inc Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 141. Covis Pharmaceutical Inc Recent Development
Table 142. Roche Company Detail
Table 143. Roche Business Overview
Table 144. Roche Antiasthmatic DrugProduct
Table 145. Roche Revenue in Antiasthmatic Drug Business (2017-2022) & (US$ Million)
Table 146. Roche Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antiasthmatic Drug Market Share by Type: 2021 VS 2028
Figure 2. Bronchodilators Features
Figure 3. Anti-allergic Antiasthmatic Features
Figure 4. Anti-inflammatory Antiasthmatic Features
Figure 5. Global Antiasthmatic Drug Market Share by Application in 2021 & 2028
Figure 6. Need for Acute Attack of Asthma Case Studies
Figure 7. Treatment of Chronic Asthma Case Studies
Figure 8. Antiasthmatic Drug Report Years Considered
Figure 9. Global Antiasthmatic Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Antiasthmatic Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Antiasthmatic Drug Market Share by Region: 2021 VS 2028
Figure 12. Global Antiasthmatic Drug Market Share by Players in 2021
Figure 13. Global Top Antiasthmatic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiasthmatic Drug as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Antiasthmatic Drug Revenue in 2021
Figure 15. North America Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Antiasthmatic Drug Market Share by Country (2017-2028)
Figure 17. United States Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Antiasthmatic Drug Market Share by Country (2017-2028)
Figure 21. Germany Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Antiasthmatic Drug Market Share by Region (2017-2028)
Figure 29. China Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Antiasthmatic Drug Market Share by Country (2017-2028)
Figure 37. Mexico Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Antiasthmatic Drug Market Share by Country (2017-2028)
Figure 41. Turkey Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Antiasthmatic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Novartis AG Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 44. GlaxoSmithKline Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 45. ABC Farmaceutici Spa Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 46. AstraZeneca Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 47. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 48. Mundipharma Pharmaceuticals Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 49. MSD Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 50. Daiichi Sankyo Company Limited Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 51. Chiesi GmbH Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 52. Kyorin Pharmaceutical Co.,Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 53. Kissei Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 54. Ruiyang Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 55. Chiesi Pharmaceutical (Shangai) Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 56. Fuhe Group Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 57. Lunan Pharmaceutical Group Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 58. Chengdu Huayu Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 59. Kaifeng Kangnuo Pharmaceutical Co., Ltd Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 60. Akorn Pharmaceutical Co.Ltd. Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 61. Boehringer Ingelheim Pharma GmbH&Co.KG Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 62. Covis Pharmaceutical Inc Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 63. Roche Revenue Growth Rate in Antiasthmatic Drug Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs